The rapid proliferation of cancer cells within tumor tissue creates a hypoxic condition that triggers the angiogenic program to upregulate hypoxia-inducible factor (HIF)-1α and downstream vascular endothelial growth factor (VEGF), leading to tumor angiogenesis and tumor progression. The gene discussed is HIF1A; the disease is neoplasm.